Jarrod Longcor
2022
In 2022, Jarrod Longcor earned a total compensation of $831.8K as Chief Operating Officer at Cellectar Biosciences, a 7% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $175,320 |
---|---|
Option Awards | $206,435 |
Salary | $450,000 |
Total | $831,755 |
Longcor received $450K in salary, accounting for 54% of the total pay in 2022.
Longcor also received $175.3K in non-equity incentive plan and $206.4K in option awards.
Rankings
In 2022, Jarrod Longcor's compensation ranked 3,404th out of 5,690 executives tracked by ExecPay. In other words, Longcor earned more than 40.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,404 | 40th |
Manufacturing | 1,925 | 38th |
Chemicals And Allied Products | 920 | 35th |
Drugs | 859 | 34th |
Pharmaceutical Preparations | 624 | 34th |
Longcor's colleagues
We found two more compensation records of executives who worked with Jarrod Longcor at Cellectar Biosciences in 2022.
News
Cellectar Biosciences CEO James Caruso's 2023 pay jumps 34% to $2M
April 26, 2024
Cellectar Biosciences CEO James Caruso's 2021 pay jumps 112% to $2.2M
April 29, 2022
Cellectar Biosciences CEO James Caruso's 2020 pay rises 9% to $1M
May 13, 2021
Cellectar Biosciences CEO James Caruso's 2019 pay jumps 21% to $934K
April 28, 2020
Cellectar Biosciences CEO James Caruso's 2018 pay falls 23% to $770K
April 29, 2019